In the remaining cases, an example is CLL-56, the molecule is simply cytotoxic or triggers caspase-independent events, as evidenced by a limited caspase-3 activity and Annexin V positivity. Here, ANXA5 is linked to B-cell chronic lymphocytic leukemia.